332 related articles for article (PubMed ID: 33252839)
1. Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank.
Watts EL; Fensom GK; Smith Byrne K; Perez-Cornago A; Allen NE; Knuppel A; Gunter MJ; Holmes MV; Martin RM; Murphy N; Tsilidis KK; Yeap BB; Key TJ; Travis RC
Int J Cancer; 2021 May; 148(9):2274-2288. PubMed ID: 33252839
[TBL] [Abstract][Full Text] [Related]
2. Prospective analyses of testosterone and sex hormone-binding globulin with the risk of 19 types of cancer in men and postmenopausal women in UK Biobank.
Watts EL; Perez-Cornago A; Knuppel A; Tsilidis KK; Key TJ; Travis RC
Int J Cancer; 2021 Aug; 149(3):573-584. PubMed ID: 33720423
[TBL] [Abstract][Full Text] [Related]
3. Testosterone, sex hormone-binding globulin, insulin-like growth factor-1 and endometrial cancer risk: observational and Mendelian randomization analyses.
Mullee A; Dimou N; Allen N; O'Mara T; Gunter MJ; Murphy N
Br J Cancer; 2021 Oct; 125(9):1308-1317. PubMed ID: 34363033
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women.
Murphy N; Knuppel A; Papadimitriou N; Martin RM; Tsilidis KK; Smith-Byrne K; Fensom G; Perez-Cornago A; Travis RC; Key TJ; Gunter MJ
Ann Oncol; 2020 May; 31(5):641-649. PubMed ID: 32169310
[TBL] [Abstract][Full Text] [Related]
5. Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank.
Tin Tin S; Reeves GK; Key TJ
Br J Cancer; 2021 Jul; 125(1):126-134. PubMed ID: 33864017
[TBL] [Abstract][Full Text] [Related]
6. Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia.
Watts EL; Perez-Cornago A; Fensom GK; Smith-Byrne K; Noor U; Andrews CD; Gunter MJ; Holmes MV; Martin RM; Tsilidis KK; Albanes D; Barricarte A; Bueno-de-Mesquita B; Chen C; Cohn BA; Dimou NL; Ferrucci L; Flicker L; Freedman ND; Giles GG; Giovannucci EL; Goodman GE; Haiman CA; Hankey GJ; Huang J; Huang WY; Hurwitz LM; Kaaks R; Knekt P; Kubo T; Langseth H; Laughlin G; Le Marchand L; Luostarinen T; MacInnis RJ; Mäenpää HO; Männistö S; Metter EJ; Mikami K; Mucci LA; Olsen AW; Ozasa K; Palli D; Penney KL; Platz EA; Rissanen H; Sawada N; Schenk JM; Stattin P; Tamakoshi A; Thysell E; Tsai CJ; Tsugane S; Vatten L; Weiderpass E; Weinstein SJ; Wilkens LR; Yeap BB; ; ; ; ; ; Allen NE; Key TJ; Travis RC
Int J Cancer; 2022 Oct; 151(7):1033-1046. PubMed ID: 35579976
[TBL] [Abstract][Full Text] [Related]
7. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis.
Watts EL; Perez-Cornago A; Fensom GK; Smith-Byrne K; Noor U; Andrews CD; Gunter MJ; Holmes MV; Martin RM; Tsilidis KK; Albanes D; Barricarte A; Bueno-de-Mesquita HB; Cohn BA; Deschasaux-Tanguy M; Dimou NL; Ferrucci L; Flicker L; Freedman ND; Giles GG; Giovannucci EL; Haiman CA; Hankey GJ; Holly JMP; Huang J; Huang WY; Hurwitz LM; Kaaks R; Kubo T; Le Marchand L; MacInnis RJ; Männistö S; Metter EJ; Mikami K; Mucci LA; Olsen AW; Ozasa K; Palli D; Penney KL; Platz EA; Pollak MN; Roobol MJ; Schaefer CA; Schenk JM; Stattin P; Tamakoshi A; Thysell E; Tsai CJ; Touvier M; Van Den Eeden SK; Weiderpass E; Weinstein SJ; Wilkens LR; Yeap BB; ; Allen NE; Key TJ; Travis RC
Int J Epidemiol; 2023 Feb; 52(1):71-86. PubMed ID: 35726641
[TBL] [Abstract][Full Text] [Related]
8. Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses.
Dimou N; Mori N; Harlid S; Harbs J; Martin RM; Smith-Byrne K; Papadimitriou N; Bishop DT; Casey G; Colorado-Yohar SM; Cotterchio M; Cross AJ; Marchand LL; Lin Y; Offit K; Onland-Moret NC; Peters U; Potter JD; Rohan TE; Weiderpass E; Gunter MJ; Murphy N
Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1336-1348. PubMed ID: 33879453
[TBL] [Abstract][Full Text] [Related]
9. Circulating Insulin-Like Growth Factor-1 and Risk of Total and 19 Site-Specific Cancers: Cohort Study Analyses from the UK Biobank.
Qian F; Huo D
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2332-2342. PubMed ID: 32856611
[TBL] [Abstract][Full Text] [Related]
10. Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank.
Knuppel A; Fensom GK; Watts EL; Gunter MJ; Murphy N; Papier K; Perez-Cornago A; Schmidt JA; Smith Byrne K; Travis RC; Key TJ
Cancer Res; 2020 Sep; 80(18):4014-4021. PubMed ID: 32709735
[TBL] [Abstract][Full Text] [Related]
11. Circulating insulin-like growth factor-I and risk of 25 common conditions: outcome-wide analyses in the UK Biobank study.
Papier K; Knuppel A; Perez-Cornago A; Watts EL; Tong TYN; Schmidt JA; Allen N; Key TJ; Travis RC
Eur J Epidemiol; 2022 Jan; 37(1):25-34. PubMed ID: 34746972
[TBL] [Abstract][Full Text] [Related]
12. Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.
Bonilla C; Lewis SJ; Rowlands MA; Gaunt TR; Davey Smith G; Gunnell D; Palmer T; Donovan JL; Hamdy FC; Neal DE; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Grönberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; ; Lathrop M; Martin RM; Holly JM
Int J Cancer; 2016 Oct; 139(7):1520-33. PubMed ID: 27225428
[TBL] [Abstract][Full Text] [Related]
13. Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a Mendelian randomization analysis.
Hazelwood E; Sanderson E; Tan VY; Ruth KS; Frayling TM; Dimou N; Gunter MJ; Dossus L; Newton C; Ryan N; Pournaras DJ; O'Mara TA; Davey Smith G; Martin RM; Yarmolinsky J
BMC Med; 2022 Apr; 20(1):125. PubMed ID: 35436960
[TBL] [Abstract][Full Text] [Related]
14. Pre-diagnostic free androgen and estradiol levels influence heart failure risk in both women and men: A prospective cohort study in the UK Biobank.
Lim J; Hashemian M; Blechter B; Roger VL; Wong JYY
Eur J Heart Fail; 2024 Mar; 26(3):540-550. PubMed ID: 38528787
[TBL] [Abstract][Full Text] [Related]
15. Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer.
Rowlands MA; Holly JM; Hamdy F; Phillips J; Goodwin L; Marsden G; Gunnell D; Donovan J; Neal DE; Martin RM
Cancer Causes Control; 2012 Feb; 23(2):347-54. PubMed ID: 22183619
[TBL] [Abstract][Full Text] [Related]
16. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses.
Murphy N; Carreras-Torres R; Song M; Chan AT; Martin RM; Papadimitriou N; Dimou N; Tsilidis KK; Banbury B; Bradbury KE; Besevic J; Rinaldi S; Riboli E; Cross AJ; Travis RC; Agnoli C; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Onland-Moret NC; Burnett-Hartman A; Campbell PT; Casey G; Castellví-Bel S; Chang-Claude J; Chirlaque MD; de la Chapelle A; English D; Figueiredo JC; Gallinger SJ; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Ose J; Perduca V; Phipps AI; Platz EA; Potter JD; Qu C; Rennert G; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Vymetalkova V; Wang H; White E; Wolk A; Woods MO; Wu AH; Zheng W; Peters U; Gunter MJ
Gastroenterology; 2020 Apr; 158(5):1300-1312.e20. PubMed ID: 31884074
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
[TBL] [Abstract][Full Text] [Related]
18. Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutrition.
Cheng TS; Noor U; Watts E; Pollak M; Wang Y; McKay J; Atkins J; Masala G; Sánchez MJ; Agudo A; Castilla J; Aune D; Colorado-Yohar SM; Manfredi L; Gunter MJ; Pala V; Josefsson A; Key TJ; Smith-Byrne K; Travis RC
BMC Cancer; 2024 Jun; 24(1):676. PubMed ID: 38831273
[TBL] [Abstract][Full Text] [Related]
19. Interactions of obesity, body shape, diabetes and sex steroids with respect to prostate cancer risk in the UK Biobank cohort.
Christakoudi S; Tsilidis KK; Evangelou E; Riboli E
Cancer Med; 2024 Feb; 13(3):e6918. PubMed ID: 38234143
[TBL] [Abstract][Full Text] [Related]
20. Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Tsilidis KK; Travis RC; Appleby PN; Allen NE; Lindstrom S; Schumacher FR; Cox D; Hsing AW; Ma J; Severi G; Albanes D; Virtamo J; Boeing H; Bueno-de-Mesquita HB; Johansson M; Quirós JR; Riboli E; Siddiq A; Tjønneland A; Trichopoulos D; Tumino R; Gaziano JM; Giovannucci E; Hunter DJ; Kraft P; Stampfer MJ; Giles GG; Andriole GL; Berndt SI; Chanock SJ; Hayes RB; Key TJ
Am J Epidemiol; 2012 May; 175(9):926-35. PubMed ID: 22459122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
